secwatch.observer — SEC 8-K summary
======================================

Issuer:     Chemomab Therapeutics Ltd. (CMMB)
CIK:        0001534248
Form:       8-K
Filed at:   2021-11-10T23:59:59+00:00
Accession:  0001178913-21-003475
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemomab Therapeutics files updated corporate presentation on November 10, 2021
-------------------------------------------------------------------------------

- Filed Form 8-K on Nov 10, 2021, including Items 7.01 (Regulation FD) and 9.01 (Exhibits).
- Attached updated corporate presentation as Exhibit 99.1, highlighting treatments for fibrotic diseases.
- Company based in Kiryat Atidim, Tel Aviv, with ADS trading on Nasdaq under ticker CMMB.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534248/000117891321003475/0001178913-21-003475-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534248/000117891321003475/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001178913-21-003475

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer